This week’s reported global health innovation funding included:

Gaia Family raised a $100M debt facility from Viola Credit to scale its outcome-protected fertility financing platform across the United States. The New York, NY-based company uses AI to match patients with fertility clinics based on their specific profiles and offers financing that covers additional treatment cycles if an IVF cycle fails, an embryo transfer doesn't result in a live birth, or a target number of eggs isn't retrieved during freezing. <source>

Garner Health raised $100M from Index Ventures, with participation from Kleiner Perkins, Redpoint, Thrive, Sequoia, Founders Fund, and Kaiser Permanente Ventures. The New York, NY-based platform analyzes billions of healthcare data points to identify high-performing providers and aligns financial incentives so employees can access those doctors with reduced or eliminated out-of-pocket costs. <source>

ClearNote Health raised $52M from Mattias Westman, Sandy Weill, co-founder Dr. Stephen Quake, a Seattle-based family office, and other U.S. and international institutional investors. The San Diego, CA-based company develops noninvasive blood-based early detection tests for pancreatic and ovarian cancers, using a multiomic approach and machine learning to identify early-stage disease in high-risk patient populations. <source>

H1 raised $40M from CVS Health Ventures. The New York, NY-based platform aggregates and structures detailed data on physicians globally, enabling pharma companies, hospital systems, and health insurers to identify and engage healthcare providers. <source>

Omniscient raised $27.2M (AU$41.1M) co-led by OIF Ventures and the Australian National Reconstruction Fund Corporation, with continued support from Will Vicars and Gina Rinehart AO. The Sydney, Australia-based company's FDA-cleared Quicktome platform uses AI to generate patient-specific connectomic brain maps, giving clinicians visibility into functional regions and neural pathways to support surgical planning across neurological conditions including neuro-oncology, stroke, and movement disorders. <source>

Triomics raised $22M led by Battery Ventures, with participation from Nexus Venture Partners, Lightspeed, Y Combinator, Oncology Ventures, and Precision Health Informatics. The New York, NY-based company builds AI infrastructure purpose-built for oncology workflows, turning complex, longitudinal cancer records into structured intelligence to support clinical trial matching, pre-visit chart preparation, and cancer registry abstraction. <source>

Solstice raised $21M led by Transformation Capital, with participation from Twelve Below and Virtue Ventures. The New York, NY-based AI-native pharmaceutical marketing platform automates medical, legal, and regulatory review workflows, compressing standard asset-delivery cycles and reducing average MLR review iterations. <source>

Signos raised $20M from GV (Google Ventures), Dexcom, and Blue Cross Blue Shield of Alabama. The Palo Alto, CA-based company offers the first FDA-cleared over-the-counter continuous glucose monitoring system for weight management, using AI to generate personalized metabolic insights from glucose data tied to diet, exercise, sleep, and stress. <source>

Ember LifeSciences raised $10.5M in additional Series A investment from Amgen Ventures and TDF Ventures, bringing its total Series A to $27M. The Westlake Village, CA-based company provides the Ember Cube 2, a reusable, modular cold chain shipping solution with real-time temperature monitoring and cloud-based tracking for pharmaceutical distributors, specialty pharmacies, and healthcare networks. <source>

SOND raised $7M from E14 Fund, Crosslink Capital, Ubiquity Ventures, Alumni Ventures, Meach Cove Capital, and Boston Scientific co-founder John Abele. The Boston, MA-based company emerged from stealth with Dreambuds, an in-ear wearable system that captures 12 physiological signals in real time and uses an AI sleep coach to select or generate audio programs that actively intervene to improve sleep quality. <source>

Kubera Health raised $6.5M led by Upfront Ventures, with participation from Company Ventures, Dria Ventures, and SemperVirens. The New York, NY-based company builds a contract-to-payment system of record for healthcare, translating payor-provider agreements into structured rules applied continuously against claims and payment data to surface and resolve inaccurate payments. <source>

Sychedelic raised $3.5M from TurboStart, Ideabaaz, and Praveek Ventures, along with angel investors from India, the UAE, and the NRI community. The New Delhi, India- and New York, NY-based company develops AI-powered neurotech wearables at the intersection of neuroscience and biofeedback technology for mental wellness applications. <source>

Paralign Health raised $3M led by Flyover Capital, with participation from SixThirty Ventures, Springtime Ventures, Forum Ventures, Sorenson Impact Foundation, Stone Mountain Ventures, and GovTech Ventures. The Kansas City, MO-based company enables health plans to activate local fire departments and EMS agencies to deliver in-home preventative care to high-risk members in rural and underserved communities. <source>

Captive Radiology received a growth investment from RC Capital. The North Canton, OH-based company provides turnkey diagnostic imaging solutions – including project management, staffing, quality assurance, and equipment – to hospitals, physician groups, and specialty facilities in nearly 20 states. <source>

Celito Tech received a growth investment from Achieve Partners. The Palo Alto, CA-based life sciences consulting firm provides tech-enabled regulatory, compliance, and IT services – including clinical quality assurance, cybersecurity, cloud migration, and Veeva support – to biotech and pharmaceutical companies. <source>

Mitsu raised a new investment round from existing investors and new backers including Gaurav Agarwal, Sanjay Suri, Gaurav Bhatnagar, Hemant Joshi, and Manish Dhingra. The Mumbai, India-based company operates tech-enabled mental health clinics combining in-person and virtual therapy and psychiatry services alongside a digital platform with personalized self-care tools and clinician support. <source>

Data is from StartUp Health Insights, the most comprehensive funding database for health innovation. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox. Follow us on LinkedIn for daily updates on Health Moonshots.